Interleukin-2 associated linear IgA bullous dermatosis
- 30 November 1996
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 35 (5) , 865-867
- https://doi.org/10.1016/s0190-9622(96)90106-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: The university of Chicago experienceUrology, 1996
- Cutaneous reactions to recombinant cytokine therapyJournal of the American Academy of Dermatology, 1995
- Amiodarone-induced linear IgA diseaseJournal of the American Academy of Dermatology, 1994
- Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.Journal of Clinical Oncology, 1992
- Interleukin-2-Induced Dermatotoxicity Resembling Toxic Epidermal NecrolysisSouthern Medical Journal, 1992
- Reversible Cardiomyopathy After High-Dose Interleukin-2 TherapyJournal of Immunotherapy, 1992
- Clinical Toxicity of Interleukin-2Drug Safety, 1992
- Life-Threatening Bullous Skin Eruptions During Interleukin-2 TherapyJNCI Journal of the National Cancer Institute, 1991
- Linear IgA dermatosis: Association with malignancyJournal of the American Academy of Dermatology, 1990
- A case of fatalPemphigus Vulgaris in association with beta interferon and interleukin-2 therapyCancer, 1989